Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Korea Bone Bank CO.,LTD. Receives KFDA Approval


Thursday, 27 Dec 2012 08:55pm EST 

Korea Bone Bank CO.,LTD. announced that it has received Korea Food & Drug Administration (KFDA) approval, on December 28, 2012, to manufacture bone grafting material. 

Company Quote

2780.0
-50.0 -1.77%
11 Jul 2014